Woman who loves God, my family, & my country, as well as Freedom lovers worldwide. Not here for followers. #FamilyIsEverything #GodWins

Ivermectin for prostate cancer

Ivermectin inhibits AR pathway in prostate cancer models.

Resistance to AR pathway inhibitors in prostate cancer is associated with AR amplification, mutations, and expression of truncated AR variants, the latter characterized by loss of AR’s ligand-binding domain and constitutively active transcription (24).
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6994194/#:~:text=Ivermectin%20inhibits%20AR%20pathway%20in,constitutively%20active%20transcription%20(24).

Only people mentioned by @suehack in this post can reply

No replys yet!

It seems that this publication does not yet have any comments. In order to respond to this publication from Susan Hackler, click on at the bottom under it